Global Health Delivers Strong Q2 FY27 Growth Driven by Patient Volumes and Noida Breakeven
Global Health Ltd 路 Investor Presentation 路 03 Nov 2026, 10:51 pm
Global Health Delivers Strong Q2 FY27 Growth Driven by Patient Volumes and Noida Breakeven Global Health reported robust Q2 FY27 performance, with revenue from operations rising 33.6% YoY to INR 14,690 mn and operating EBITDA surging 60.2% YoY to INR 3,701 mn, expanding margins 418 bps to 25.2%. PAT grew 38.3% YoY to INR 2,191 mn. Operational momentum was underpinned by strong volume growth, with IPD and OPD volumes up 29.5% and 37.9% YoY, respectively, alongside Noida achieving EBITDA breakeven at INR 86 mn. As of 30th Sep'26, net cash stood at INR 7,815 mn, supporting a ~INR 62,390 mn expansion pipeline.
Original exchange filing (PDF)
More announcements from Global Health Ltd
- Intimation of Credit Rating by Crisil. 路 18 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 18 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 16 Nov 2026
- Investor Presentation for the Analyst/Investors Meet . 路 14 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
